Global Cell Therapy Manufacturing Market Size, Share, Trend and Forecast 2026 | TechSci Research

1
2016 2026
GLOBAL CELL THERAPY MANUFACTURING MARKET
FORECAST OPPORTUNITIES
www.techsciresearch.com
MARKET INTELLIGENCE . CONSULTING
2

• Scope of Report
• Product of Interest (POI) Cell Therapy
  Manufacturing

Cell therapy (also called cellular therapy, cell
transplantation, or cytotherapy) is a therapy in
which viable cells are injected, grafted or
implanted into a patient in order to effectuate a
medicinal effect, for example, by transplanting
T-cells capable of fighting cancer cells via
cell-mediated immunity in the course of
immunotherapy, or grafting stem cells to
regenerate diseased tissues.
Market Segmentation
APPLICATION
SCALE OF OPERATION
THERAPY

• Preclinical
• Clinical
• Commercial

• T-Cell Therapies
• Dendritic Cell Therapies
• Tumor Cell Therapies
• Stem Cell Therapies

• Oncology
• Cardiovascular Diseases
• Orthopedic Diseases
• Others

SOURCE
END USER
REGION

• In-House
• Contract Manufacturing

• Pharmaceutical Biotechnology Companies
• Academic Research Institutes
• Others

• Asia-Pacific
• Europe
• North America
• South America
• Middle East Africa (MEA)

SOURCE OF CELL

• Autologous
• Allogenic

3

• Table of Contents

S. No. Contents Contents Contents Page No.
1. Product Overview Product Overview Product Overview
2. Research Methodology Research Methodology Research Methodology
3. Impact of COVID-19 on Global Cell Therapy Manufacturing Market Impact of COVID-19 on Global Cell Therapy Manufacturing Market Impact of COVID-19 on Global Cell Therapy Manufacturing Market
4. Executive Summary Executive Summary Executive Summary
5. Voice of Customer Voice of Customer Voice of Customer
5.1. Popularly used cells for Cell Therapy Manufacturing Popularly used cells for Cell Therapy Manufacturing
5.2. Commonly Used Cell Therapies Commonly Used Cell Therapies
5.3. Brand Awareness Brand Awareness
6. Global Cell Therapy Manufacturing Market Outlook Global Cell Therapy Manufacturing Market Outlook Global Cell Therapy Manufacturing Market Outlook
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies) By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)
6.2.2. By Source of Cell (Autologous v/s Allogenic) By Source of Cell (Autologous v/s Allogenic)
6.2.3. By Scale of Operation (Preclinical, Clinical, Commercial) By Scale of Operation (Preclinical, Clinical, Commercial)
6.2.4. By Source (In-House v/s Contract Manufacturing) By Source (In-House v/s Contract Manufacturing)
6.2.5. By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others) By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)
6.2.6. By End User (Pharmaceutical Biotechnology Companies, Academic Research Institutes, Others) By End User (Pharmaceutical Biotechnology Companies, Academic Research Institutes, Others)
6.2.7. By Company (2020) By Company (2020)
6.2.8. By Region (Asia-Pacific, Europe, North America, South America and Middle East Africa) By Region (Asia-Pacific, Europe, North America, South America and Middle East Africa)
6.3. Product Market Map Product Market Map Product Market Map
4

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7. Asia-Pacific Cell Therapy Manufacturing Market Outlook Asia-Pacific Cell Therapy Manufacturing Market Outlook Asia-Pacific Cell Therapy Manufacturing Market Outlook Asia-Pacific Cell Therapy Manufacturing Market Outlook Asia-Pacific Cell Therapy Manufacturing Market Outlook
7.1. Market Size Forecast Market Size Forecast Market Size Forecast
7.1.1. By Value By Value By Value
7.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
7.2.1. By Therapy By Therapy By Therapy
7.2.2. By Source of Cell By Source of Cell By Source of Cell
7.2.3. By Scale of Operation By Scale of Operation By Scale of Operation
7.2.4. By Source By Source By Source
7.2.5. By Application By Application By Application
7.2.6. By End User By End User By End User
7.2.7. By Country By Country By Country
7.3. Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis
7.3.1. China Cell Therapy Manufacturing Market Outlook China Cell Therapy Manufacturing Market Outlook China Cell Therapy Manufacturing Market Outlook
7.3.1.1. Market Size Forecast Market Size Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share Forecast Market Share Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Source of Cell
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Source
7.3.1.2.5. By Application
7.3.1.2.6. By End User
5

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7.3.2. India Cell Therapy Manufacturing Market Outlook India Cell Therapy Manufacturing Market Outlook India Cell Therapy Manufacturing Market Outlook
7.3.2.1. Market Size Forecast Market Size Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share Forecast Market Share Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Source of Cell
7.3.2.2.3. By Scale of Operation
7.3.2.2.4 By Source
7.3.2.2.5. By Application
7.3.2.2.6. By End User
7.3.3. Australia Cell Therapy Manufacturing Market Outlook Australia Cell Therapy Manufacturing Market Outlook Australia Cell Therapy Manufacturing Market Outlook
7.3.3.1. Market Size Forecast Market Size Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share Forecast Market Share Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Source of Cell
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Source
7.3.3.2.5. By Application
7.3.3.2.6. By End User
6

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7.3.4. Japan Cell Therapy Manufacturing Market Outlook Japan Cell Therapy Manufacturing Market Outlook Japan Cell Therapy Manufacturing Market Outlook
7.3.4.1. Market Size Forecast Market Size Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share Forecast Market Share Forecast
7.3.4.2.1. By Therapy
7.3.4.2.2. By Source of Cell
7.3.4.2.3. By Scale of Operation
7.3.4.2.4 By Source
7.3.4.2.5. By Application
7.3.4.2.6. By End User
7.3.5. South Korea Cell Therapy Manufacturing Market Outlook South Korea Cell Therapy Manufacturing Market Outlook South Korea Cell Therapy Manufacturing Market Outlook
7.3.5.1. Market Size Forecast Market Size Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share Forecast Market Share Forecast
7.3.5.2.1. By Therapy
7.3.5.2.2. By Source of Cell
7.3.5.2.3. By Scale of Operation
7.3.5.2.4. By Source
7.3.5.2.5. By Application
7.3.5.2.6. By End User
7

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8. Europe Cell Therapy Manufacturing Market Outlook Europe Cell Therapy Manufacturing Market Outlook Europe Cell Therapy Manufacturing Market Outlook Europe Cell Therapy Manufacturing Market Outlook Europe Cell Therapy Manufacturing Market Outlook
8.1. Market Size Forecast Market Size Forecast Market Size Forecast
8.1.1. By Value By Value By Value
8.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
8.2.1. By Therapy By Therapy By Therapy
8.2.2. By Source of Cell By Source of Cell By Source of Cell
8.2.3. By Scale of Operation By Scale of Operation By Scale of Operation
8.2.4. By Source By Source By Source
8.2.5. By Application By Application By Application
8.2.6. By End User By End User By End User
8.2.7. By Country By Country By Country
8.3. Europe Country Analysis Europe Country Analysis Europe Country Analysis Europe Country Analysis
8.3.1. France Cell Therapy Manufacturing Market Outlook France Cell Therapy Manufacturing Market Outlook France Cell Therapy Manufacturing Market Outlook
8.3.1.1. Market Size Forecast Market Size Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share Forecast Market Share Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Source of Cell
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Source
8.3.1.2.5. By Application
8.3.1.2.6. By End User
8

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8.3.2. Germany Cell Therapy Manufacturing Market Outlook Germany Cell Therapy Manufacturing Market Outlook Germany Cell Therapy Manufacturing Market Outlook
8.3.2.1. Market Size Forecast Market Size Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share Forecast Market Share Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Source of Cell
8.3.2.2.3. By Scale of Operation
8.3.2.2.4 By Source
8.3.2.2.5. By Application
8.3.2.2.6. By End User
8.3.3. United Kingdom Cell Therapy Manufacturing Market Outlook United Kingdom Cell Therapy Manufacturing Market Outlook United Kingdom Cell Therapy Manufacturing Market Outlook
8.3.3.1. Market Size Forecast Market Size Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share Forecast Market Share Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Source of Cell
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Source
8.3.3.2.5. By Application
8.3.3.2.6. By End User
9

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8.3.4. Italy Cell Therapy Manufacturing Market Outlook Italy Cell Therapy Manufacturing Market Outlook Italy Cell Therapy Manufacturing Market Outlook
8.3.4.1. Market Size Forecast Market Size Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share Forecast Market Share Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Source of Cell
8.3.4.2.3. By Scale of Operation
8.3.4.2.4 By Source
8.3.4.2.5. By Application
8.3.4.2.6. By End User
8.3.5. Spain Cell Therapy Manufacturing Market Outlook Spain Cell Therapy Manufacturing Market Outlook Spain Cell Therapy Manufacturing Market Outlook
8.3.5.1. Market Size Forecast Market Size Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share Forecast Market Share Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Source of Cell
8.3.5.2.3. By Scale of Operation
8.3.5.2.4. By Source
8.3.5.2.5. By Application
8.3.5.2.6. By End User
10

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
9. North America Cell Therapy Manufacturing Market Outlook North America Cell Therapy Manufacturing Market Outlook North America Cell Therapy Manufacturing Market Outlook North America Cell Therapy Manufacturing Market Outlook North America Cell Therapy Manufacturing Market Outlook
9.1. Market Size Forecast Market Size Forecast Market Size Forecast
9.1.1. By Value By Value By Value
9.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
9.2.1. By Therapy By Therapy By Therapy
9.2.2. By Source of Cell By Source of Cell By Source of Cell
9.2.3. By Scale of Operation By Scale of Operation By Scale of Operation
9.2.4. By Source By Source By Source
9.2.5. By Application By Application By Application
9.2.6. By End User By End User By End User
9.2.7. By Country By Country By Country
9.3. North America Country Analysis North America Country Analysis North America Country Analysis North America Country Analysis
9.3.1. United States Cell Therapy Manufacturing Market Outlook United States Cell Therapy Manufacturing Market Outlook United States Cell Therapy Manufacturing Market Outlook
9.3.1.1. Market Size Forecast Market Size Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share Forecast Market Share Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Source of Cell
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Source
9.3.1.2.5. By Application
9.3.1.2.6. By End User
11

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
9.3.2. Canada Cell Therapy Manufacturing Market Outlook Canada Cell Therapy Manufacturing Market Outlook Canada Cell Therapy Manufacturing Market Outlook
9.3.2.1. Market Size Forecast Market Size Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share Forecast Market Share Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Source of Cell
9.3.2.2.3. By Scale of Operation
9.3.2.2.4 By Source
9.3.2.2.5. By Application
9.3.2.2.6. By End User
9.3.3. Mexico Cell Therapy Manufacturing Market Outlook Mexico Cell Therapy Manufacturing Market Outlook Mexico Cell Therapy Manufacturing Market Outlook
9.3.3.1. Market Size Forecast Market Size Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share Forecast Market Share Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Source of Cell
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Source
9.3.3.2.5. By Application
9.3.3.2.6. By End User
12

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
10. South America Cell Therapy Manufacturing Market Outlook South America Cell Therapy Manufacturing Market Outlook South America Cell Therapy Manufacturing Market Outlook South America Cell Therapy Manufacturing Market Outlook South America Cell Therapy Manufacturing Market Outlook
10.1. Market Size Forecast Market Size Forecast Market Size Forecast
10.1.1. By Value By Value By Value
10.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
10.2.1. By Therapy By Therapy By Therapy
10.2.2. By Source of Cell By Source of Cell By Source of Cell
10.2.3. By Scale of Operation By Scale of Operation By Scale of Operation
10.2.4. By Source By Source By Source
10.2.5. By Application By Application By Application
10.2.6. By End User By End User By End User
10.2.7. By Country By Country By Country
10.3. South America Country Analysis South America Country Analysis South America Country Analysis South America Country Analysis
10.3.1. Brazil Cell Therapy Manufacturing Market Outlook Brazil Cell Therapy Manufacturing Market Outlook Brazil Cell Therapy Manufacturing Market Outlook
10.3.1.1. Market Size Forecast Market Size Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share Forecast Market Share Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Source of Cell
10.3.1.2.3. By Scale of Operation
10.3.1.2.4. By Source
10.3.1.2.5. By Application
10.3.1.2.6. By End User
13

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
10.3.2. Argentina Cell Therapy Manufacturing Market Outlook Argentina Cell Therapy Manufacturing Market Outlook Argentina Cell Therapy Manufacturing Market Outlook
10.3.2.1. Market Size Forecast Market Size Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share Forecast Market Share Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Source of Cell
10.3.2.2.3. By Scale of Operation
10.3.2.2.4 By Source
10.3.2.2.5. By Application
10.3.2.2.6. By End User
10.3.3. Colombia Cell Therapy Manufacturing Market Outlook Colombia Cell Therapy Manufacturing Market Outlook Colombia Cell Therapy Manufacturing Market Outlook
10.3.3.1. Market Size Forecast Market Size Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share Forecast Market Share Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Source of Cell
10.3.3.2.3. By Scale of Operation
10.3.3.2.4. By Source
10.3.3.2.5. By Application
10.3.3.2.6. By End User
14

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11. Middle East Africa Cell Therapy Manufacturing Market Outlook Middle East Africa Cell Therapy Manufacturing Market Outlook Middle East Africa Cell Therapy Manufacturing Market Outlook Middle East Africa Cell Therapy Manufacturing Market Outlook Middle East Africa Cell Therapy Manufacturing Market Outlook
11.1. Market Size Forecast Market Size Forecast Market Size Forecast
11.1.1. By Value By Value By Value
11.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
11.2.1. By Therapy By Therapy By Therapy
11.2.2. By Source of Cell By Source of Cell By Source of Cell
11.2.3. By Scale of Operation By Scale of Operation By Scale of Operation
11.2.4. By Source By Source By Source
11.2.5. By Application By Application By Application
11.2.6. By End User By End User By End User
11.2.7. By Country By Country By Country
11.3. Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis
11.3.1. South Africa Cell Therapy Manufacturing Market Outlook South Africa Cell Therapy Manufacturing Market Outlook South Africa Cell Therapy Manufacturing Market Outlook
11.3.1.1. Market Size Forecast Market Size Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share Forecast Market Share Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Source of Cell
11.3.1.2.3. By Scale of Operation
11.3.1.2.4. By Source
11.3.1.2.5. By Application
11.3.1.2.6. By End User
15

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11.3.2. Saudi Arabia Cell Therapy Manufacturing Market Outlook Saudi Arabia Cell Therapy Manufacturing Market Outlook Saudi Arabia Cell Therapy Manufacturing Market Outlook
11.3.2.1. Market Size Forecast Market Size Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share Forecast Market Share Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Source of Cell
11.3.2.2.3. By Scale of Operation
11.3.2.2.4 By Source
11.3.2.2.5. By Application
11.3.2.2.6. By End User
11.3.3. UAE Cell Therapy Manufacturing Market Outlook UAE Cell Therapy Manufacturing Market Outlook UAE Cell Therapy Manufacturing Market Outlook
11.3.3.1. Market Size Forecast Market Size Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share Forecast Market Share Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Source of Cell
11.3.3.2.3. By Scale of Operation
11.3.3.2.4. By Source
11.3.3.2.5. By Application
11.3.3.2.6. By End User
16

• Table of Contents

S. No. Contents Page No.
12. Market Dynamics Market Dynamics Market Dynamics
12.1.. Drivers Drivers
12.2. Challenges Challenges
13. Market Trends Developments Market Trends Developments Market Trends Developments
14. Competitive Landscape Competitive Landscape Competitive Landscape
14.1. Players Profiled (Leading Companies) Players Profiled (Leading Companies)
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled) Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Company Details
14.2.2. Products Services
14.2.3. Financials (As Reported)
14.2.4. Key Market Focus Geographical Presence
14.2.5. Recent Developments
14.2.6. Key Management Personnel
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About Us Disclaimer About Us Disclaimer About Us Disclaimer
17
RESEARCH METHODOLOGY
18

• Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing List of Respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine top players in the global cell therapy
manufacturing market, overall market size and
segmental market size.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the global cell therapy
manufacturing market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Conclusion

• Market Participants
• Key Strengths

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

19

• Research Methodology

• Baseline Methodology
• Our dedicated team of industry experts has
  monitored and analyzed various aspects of the
  global cell therapy manufacturing market. The
  team has analyzed the outlook of various segments
  of this market, while considering the major
  influencing factors such as ongoing advancements
  in research and development of cell therapy
  manufacturing. The study includes market
  forecasting, which would enable our clients to
  take better decisions while planning their
  strategy to achieve sustainability in the global
  cell therapy manufacturing market.
• Methodology Followed for Calculation of Market
  Size
• Market Size by Value Market size, in terms of
  value, for the year 2020 was calculated based on
  information collected through exhaustive
  secondary research and primary surveys, with
  various key opinion leaders/stakeholders, such as
  cell therapy manufacturing companies, channel
  partners, market influencers end users,
  industry experts, and other industry
  participants.
• The team interviewed more than 15 20 cell
  therapy manufacturing companies, 100 120 end
  users, and 15 20 industry experts and other
  value chain stakeholders in the global cell
  therapy manufacturing market to obtain the
  overall market size from 2016 to 2020, which was
  validated by the Delphi technique. Taking
  standard deviation into consideration, the market
  size was averaged out, to arrive at the market
  size data during 2016-2020.

20

• Research Methodology

• Respondents were asked about the current and
  future market growth rates, market shares by
  therapy, by source of cell, by scale of
  operation, by source, by application, by end
  user, by region and by company. Removing the
  outlier responses, the geometric mean of growth
  estimates and provider wise revenue shares
  generated across various segments were
  considered, to arrive at the final revenue
  shares. Revenue shares generated across various
  segments were further triangulated from other
  stakeholders.
• Methodology Followed for Calculation of Market
  Shares
• Market shares by therapy, by source of cell, by
  scale of operation, by source, by application, by
  end user, by region and by company were
  calculated based on the responses received
  through primary surveys with industry experts, in
  which the respondents were asked about the market
  shares or revenue generated from various segments
  of cell therapy manufacturing markets. The final
  shares were calculated by taking the geometric
  mean of the responses gathered from key opinion
  leaders after eliminating the outliers.
• Methodology Followed for Forecasting
• TechSci Research performed periodical checks on
  data collected through the surveys with logic
  checks and analyzed the survey results in
  SPSS/Tableau Software.
• Data triangulation techniques were applied to
  fill the gaps and to present a more meaningful
  picture of the market. To forecast global cell
  therapy manufacturing market, TechSci Research
  used various forecast techniques such as
• Moving Average
• Time Series Analysis
• Regression Analysis
• Econometric and Judgmental Analysis

21

• Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
It should be noted that the figures compiled are
only for the organized market including market
share data. The currency used in the report is
the Global Dollar (USD), with the market size
indicated in USD million.
Partial List of Companies Interviewed Key Secondary Materials
KBI Biopharma, Inc. Waisman Biomanufacturing Cell and Gene Therapy Catapult Thermo Fisher Scientific, Inc. Merck KGaA Catalent Inc. Lonza Group Oxford Biomedica Plc Fujifilm Cellular Dynamics, Inc. Wuxi Apptec Charles River Laboratories International, Inc. The Discovery Labs LLC ABL, Inc. BioCentriq Commercializing Living Therapies World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports News Dailies Credible Paid Databases
22

• Industry Brief

According to TechSci Research report, Global
Cell Therapy Manufacturing Market By Therapy
(T-Cell Therapies, Dendritic Cell Therapies,
Tumor Cell Therapies, Stem Cell Therapies) By
Source of Cell (Autologous v/s Allogenic) By
Scale of Operation (Preclinical, Clinical,
Commercial) By Source (In-House v/s Contract
Manufacturing) By Application (Oncology,
Cardiovascular Diseases, Orthopedic Diseases,
Others) By End User (Pharmaceutical
Biotechnology Companies, Academic Research
Institutes, Others) By Region, Competition
Forecast Opportunities, 2026, the global cell
therapy manufacturing market may potentially
project an impressive growth in the forecast
period, 2022-2026, with an impressive CAGR on the
account of consistent growth of cell therapies
that are being developed and launched. The
expansion of the biopharmaceutical companies ad
biotechnological institutes is also supporting
the growth of the global cell therapy
manufacturing market in the upcoming five years.
The complex processes of manufacturing the cell
therapies, requirement of advanced production
facilities along with the growing demand for the
cell therapy products is substantiating the
growth of the global cell therapy manufacturing
market in the next five years. Cell therapy is a
biotechnological procedure where viable cells are
injected, grafted, or implanted into the human
body that requires it as a part of a medical
treatment. Major example can be understood by the
use of T-cells for the treatment of cancerous
cells in the patient. The global cell therapy
manufacturing market is segmented on the basis of
therapy, source of cell, scale of operation,
source, application, end user, competitional
landscape, and regional distribution. Based on
application, the market is again sub-segmented
into oncology, cardiovascular diseases,
orthopedic diseases, and others. Oncology is
expected to generate the maximum revenue shares
in the market and assert its dominance over the
market segments on the account of increases
research and studies in the field of oncology.
Moreover, the number of cases where the patient
is suffering due to cancer or different type of
cancers is also multiplying globally. Cell
therapy is one of the most incorporated
procedures for understanding the growth of the
cancerous cells and to overcome the cancer
causing cells in the body. The method is actively
utilized and thus aiding the growth of the
application. This rapid growth is further aiding
the growth of the global cell therapy
manufacturing market in the subsequent five
years. Cardiovascular diseases are anticipated to
hold a significant growth in the upcoming five
years on the account of increasing instances of
treatment for cardiovascular diseases using cell
therapy. Based on basis of therapy, the market
is further bifurcated into T-cell therapies,
dendritic cell therapies, tumor cell therapies,
and stem cell therapies. Stem cell therapy is
anticipated to hold the largest shares of the
market and dominate the segment in the next five
years on the account of rising research and
development in the area. Stem cells therapy are
utilized for the cures of various chronic
diseases and the consistent efforts to provide
the best available treatment to the patients.
Additionally, growing number of ongoing clinical
trials and increased stem cell therapy products
in the market is aiding the growth of the global
cell therapy manufacturing market in the upcoming
five years. Rising FDA approvals, and dedicated
biopharma companies for the consistent evolution
of the cell therapies are also substantiating the
growth of the global cell therapy manufacturing
market in the next five years. Holding the major
shares of the global cell therapy manufacturing
market are KBI Biopharma, Inc., Waisman
Biomanufacturing, Cell and Gene Therapy Catapult,
Thermo Fisher Scientific, Inc., Merck KGaA,
Catalent Inc., Lonza Group, Oxford Biomedica Plc,
Fujifilm Cellular Dynamics, Inc., Wuxi Apptec,
Charles River Laboratories International, Inc.,
The Discovery Labs LLC, ABL, Inc., BioCentriq,
Commercializing Living Therapies, among others.
Market players are actively involved in the
research and technological development in the
medical applications of the cell therapy and
related developments. The advanced technology has
made it possible for the healthcare industry to
provide excellent healthcare services through
cell therapy manufacturing. Further advancement
would aid the market value and brand
establishment in the future five years. New
market players may focus on the research and
development to provide options that satisfies the
consumer demand as well as benefits the market
players in building their brand value. Other
competitive strategies include mergers
acquisitions and new product developments. North
America is anticipated to dominate the market in
the upcoming five years of the forecast on the
account of the most evolved healthcare facility
of the larger economies like United States and
Canada. The number of ongoing clinical trials is
rapidly increasing and with the consistent
research and development from the
biopharmaceutical companies in region, the market
is expected to experience a robust growth. New
market players would be required to invest their
resources and finances into extensive research
and development of the advanced cell therapy
manufacturing products and these factors would
aid their future growth susbtantially, said Mr.
Karan Chechi, Research Director with TechSci
Research, a research based Global management
consulting firm.
23

• Sample Data - Snapshot

Global Cell Therapy Manufacturing Market Size, By
Value (USD Million), 2016-2026F
CAGR By Value
CAGR By Value
XX
YY
North America Cell Therapy Manufacturing Market
Share, By Therapy, By Value, 20162026F
United States Cell Therapy Manufacturing Market
Share, By Source of Cell, By Value, 20162026F
24

• Report Ordering

Report Name GLOBAL CELL THERAPY
MANUFACTURING MARKET FORECAST
OPPORTUNITIES 2016 2026
License Type Price
Single User License 4900
Multi-User License 5900
Custom Research License 8900
To View Sample OR Purchase Report  
25
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business models that
focus on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting models use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up model of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports

• United States Smart Hospitals Market By Component
  (Hardware, Software System, Services) By
  Technology (Cloud Computing, Artificial
  Intelligence, Wearable Technologies, Others) By
  Connectivity (Wired v/s Wireless) By Application
  (Remote Medicine Management, Medical Connected
  Imaging, Medical Assistance, Electronic Health
  Record, Others) By Services Offered (General
  Services, Specialty, Super Specialty), By Region,
  Company Forecast Opportunities, 2026
• Saudi Arabia Ultrasound System Market By
  Technology (Diagnostic Ultrasound v/s Therapeutic
  Ultrasound) By Display Type (Black White v/s
  Colored) By Mobility (Fixed v/s Mobile) By
  Application (General Imaging, Obstetrics/Gynecolog
  y, Cardiology, Urology, Orthopedic
  Musculoskeletal, Others) By End User (Hospitals
  Clinics, Diagnostic Centers, Ambulatory Care
  Centers, Others) By Company, By Region, Forecast
  Opportunities, 2026

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and
firsthand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.